Dr. Tagawa on Updated Results of TAXYNERGY Trial in Prostate Cancer OncLive 2:25 7 years ago 103 Далее Скачать
Dr. Tagawa on BRCA2 in Patients with Prostate Cancer Receiving PSMA-Targeted Radionuclide Therapy OncLive 2:29 5 years ago 464 Далее Скачать
Dr. Tagawa on Next Steps With Sacituzumab Govitecan in Advanced Urothelial Carcinoma OncLive 1:18 5 years ago 160 Далее Скачать
Scott Tagawa, MD, on the Prostate Cancer Treatment Pipeline DocWire 4:13 4 years ago 138 Далее Скачать
Scott Tagawa MD, considers next steps in the development of the PSMA-targeted alpha emitter in mCRPC OBRoncology 2:08 4 years ago 36 Далее Скачать
Scott Tagawa, MD, on promising PSMA products in development for prostate cancer treatment OBRoncology 1:21 4 years ago 49 Далее Скачать
Dr. Tagawa on CTC in Neuroendocrine-Positive Prostate Cancer OncLive 2:06 10 years ago 352 Далее Скачать
Taxane response in prostate cancer may not be influenced by androgen receptor variations ecancer 5:20 9 years ago 111 Далее Скачать
Dr. Antonarakis Discusses AR-V7 and Response to Taxanes in Men With mCRPC OncLive 1:32 9 years ago 388 Далее Скачать
Taxanes: Pivotal Agents in the Management of Metastatic Castrate-Resistant Prostate Cancer The Society for Translational Oncology 27:13 13 years ago 627 Далее Скачать
Taxanes: Pivotal Agents in the Management of Metastatic Castrate-Resistant Prostate Cancer AlphaMed Press 27:13 10 years ago 66 Далее Скачать
How Does Prostate Cancer Chemotherapy Work? | Prolonged Survival & Improved Cure Rates | PCRI Prostate Cancer Research Institute 15:27 2 years ago 29 480 Далее Скачать
Dr. Petrylak on a Phase II Trial of PSMA ADC in Taxane-Treated mCRPC Targeted Oncology 1:23 10 years ago 67 Далее Скачать
